The creation of the world’s first self-replicating, synthetic cell heralds a new era in biology. It also prompts moral, legal, and safety questions: Analysis of the potential benefits and ethical concerns.


  • Craig Venter President, J. Craig Venter Institute
  • David Rejeski Director, Science and Technology Innovation Program, director, Project on Emerging Nanotechnologies at the Woodrow Wilson Center for International Scholars
  • Sohi Rastegar Director, Office of Emerging Frontiers in Research and Innovation Engineering Directorate, National Science Foundation
  • David Baltimore Professor of Biology and President Emeritus, CalTech

Topics + Tags


comments powered by Disqus
Most Recent Shows